Skip to content

Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk Reducing, and Preventative Strategies Using BRCA2 and BRCA2 Genetic Testing

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03319290
Enrollment
2000
Registered
2017-10-24
Start date
2017-10-17
Completion date
2020-10-17
Last updated
2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Cancer

Brief summary

Observational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.

Detailed description

The general design of this study is collecting data and reviewing the Principal Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to their specific SOP.

Interventions

GENETICBRCA1 and BRCA2

Genetic breast and ovarian cancer testing

Sponsors

PAS Research Services
CollaboratorOTHER
Data Collection Analysis Business Management
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Must be a Medical Practitioner * Medical Doctor (MD) * Doctor of Osteopathic (DO) * Physician Assistant (PA) * Advanced Practice Registered Nurse (APRN) * Nurse Practitioner (NP) * Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history

Exclusion criteria

* Government-funded insurance data cannot be included in the study.

Design outcomes

Primary

MeasureTime frameDescription
Provider Structures and Processes36 monthsPlan of Care Changes due to BRCA testing. Provider based observational survey system on the health and well-being of patients and populations

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026